Loading...
Skip to main content

   Corporate News

SYNLAB to further densify its network

SYNLAB office facade

SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, has agreed to sell its activities in Slovakia to Unilabs Group. The completion of the transaction is still subject to the approvals of the relevant authorities.

The agreed divestment aligns with SYNLAB’s overarching strategy to densify its network by focusing on countries that offer attractive strategic perspectives for the Group’s further development. Operations in Slovakia accounted for approximately 0.7% of total Group revenue in 2025.

“Through active portfolio management, we continuously review our activities, the strategic perspectives and future growth potential across our markets. As a result, we have agreed to sell our operations in Slovakia, as we see limited opportunities to further scale up,” said Mathieu Floreani, CEO of the SYNLAB Group.

“Efficient capital deployment is a key element of our Group strategy. In line with this strategy, we enhance performance and optimise our network focusing on densification within key countries while diversifying across markets," added Floreani. “We are thankful for the contribution and dedication of our highly skilled SYNLAB colleagues in Slovakia and are confident they will succeed in their new setup.”

Keywords: